Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Pandox AB publ in conjunction with MSEK 3700 financing for the acquisition of 18 hotel properties in Germany
Mandate

Vinge advises Pandox AB publ in conjunction with MSEK 3700 financing for the acquisition of 18 hotel properties in Germany

December 21, 2016

The acquired hotel portfolio was expected to contribute approximately MSEK 150 in cash revenues in 2016. The hotels fall within the upper middle class segment and are primarily operated under the trademark Leonardo Hotels. The sellers are Leopard Group and Fattal Hotels.

The transaction is conditional upon approval from the salient German public authorities.

Vinge’s team consisted of Mikael Ståhl, Helena Håkansson, André Isacson and Isabelle Jengsell.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026